tiprankstipranks
Trending News
More News >
Krebs Biochemicals & Industries Ltd. (IN:KREBSBIO)
:KREBSBIO
India Market

Krebs Biochemicals & Industries Ltd. (KREBSBIO) Financial Statements

Compare
0 Followers

Krebs Biochemicals & Industries Ltd. Financial Overview

Krebs Biochemicals & Industries Ltd.'s market cap is currently ₹1.82B. The company's EPS TTM is ₹-3.83; its P/E ratio is ―; Krebs Biochemicals & Industries Ltd. is scheduled to report earnings on May 20, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total Revenue₹ 433.12M₹ 504.21M₹ 521.34M₹ 597.03M₹ 386.06M
Gross Profit₹ 377.56M₹ -108.75M₹ 97.83M₹ -57.64M₹ -129.90M
Operating Income₹ -217.19M₹ -151.96M₹ -217.19M₹ -394.94M₹ -230.42M
EBITDA₹ -143.21M₹ -82.73M₹ -151.62M₹ -328.46M₹ -169.63M
Net Income₹ -269.39M₹ -197.28M₹ -246.92M₹ -445.27M₹ -283.59M
Balance Sheet
Cash & Short-Term Investments₹ 3.38M₹ 1.37M₹ 3.72M₹ 1.01M₹ 10.77M
Total Assets₹ 1.69B₹ 1.78B₹ 1.75B₹ 1.90B₹ 1.59B
Total Debt₹ 2.12B₹ 2.39B₹ 1.83B₹ 1.88B₹ 1.26B
Net Debt₹ 2.12B₹ 2.39B₹ 1.83B₹ 1.88B₹ 1.26B
Total Liabilities₹ 3.15B₹ 2.97B₹ 2.74B₹ 2.65B₹ 2.02B
Stockholders' Equity₹ -1.46B₹ -1.19B₹ -994.62M₹ -750.93M₹ -427.33M
Cash Flow
Free Cash Flow₹ -114.54M₹ -50.23M₹ -355.84M₹ -407.36M₹ -400.81M
Operating Cash Flow₹ -78.91M₹ 23.04M₹ -247.13M₹ -172.16M₹ -145.75M
Investing Cash Flow₹ -49.70M₹ -78.17M₹ -126.45M₹ -229.00M₹ -225.49M
Financing Cash Flow₹ 128.65M₹ 55.64M₹ 373.43M₹ 395.06M₹ 376.61M
Currency in INR

Krebs Biochemicals & Industries Ltd. Earnings and Revenue History

Krebs Biochemicals & Industries Ltd. Debt to Assets

Krebs Biochemicals & Industries Ltd. Cash Flow

Krebs Biochemicals & Industries Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis